newsfilter
← Latest News
GlobeNewswire·

Diffusion Pharmaceuticals Doses First Patients in ILD-DLCO Trial

CHARLOTTESVILLE, Va., Dec. 16, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) ("Diffusion" or the "Company"), a biopharmaceutical company developing novel therapies that enhance the body's ability to deliver oxygen to areas where